Real-time enrollment status for this post-acute sequelae of sars-cov-2 infection clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 1:14 AM UTC
| NCT Number | NCT05566483 |
| Recruiting Status | Recruiting |
| Condition | Post-acute Sequelae of SARS-CoV-2 Infection |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Colorado, Denver |
| Last Updated on CT.gov | December 4, 2025 (Dec 4, 2025) |
As of July 14, 2026: Clinical trial NCT05566483 is currently recruiting participants. This clinical trial study for post-acute sequelae of sars-cov-2 infection is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Colorado, Denver. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05566483 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05566483 was last updated Dec 4, 2025 (December 4, 2025). HelloStudys verifies this status automatically.